Lexicon Pharmaceuticals shares owned by Connor, Clark & Lunn Investment Management
Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Connor, Clark & Lunn Investment Management
from 13F filings
Historical chart of Connor, Clark & Lunn Investment Management investment in Lexicon Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Lexicon Pharmaceuticals held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lexicon Pharmaceuticals by Connor, Clark & Lunn Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $432k | 283k | 1.53 |
| 2023-09-30 | $367k | 337k | 1.09 |
| 2023-06-30 | $765k | 334k | 2.29 |
| 2023-03-31 | $506k | 208k | 2.43 |
| 2022-12-31 | $257k | 135k | 1.91 |
| 2020-12-31 | $165k | 48k | 3.42 |
| 2020-09-30 | $159k | 110k | 1.44 |
| 2020-06-30 | $141k | 71k | 1.99 |
| 2020-03-31 | $85k | 44k | 1.95 |
| 2017-12-31 | $401k | 41k | 9.88 |
| 2017-09-30 | $155k | 13k | 12.33 |
More positions owned by Connor, Clark & Lunn Investment Management
View all positions for Connor, Clark & Lunn Investment Management